Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter open-label inpatient study of IV buprenorphine in pediatric patients
2010-021955-14Phase 3Terminated
- Sponsor
- Purdue Pharma
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of buprenorphine in acute postoperative pain, acute pain and pain, sponsored by Purdue Pharma. Primary endpoints: Safety variables and Pharmacokinetic variables. Started Sep 2011; status: terminated.
02
Drugs
buprenorphine
03
Conditions
acute postoperative painacute painpain
Beyond the preview
Go deeper on 2010-021955-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021955-14.